Identification of patients most likely to carry a germline mutation in the hMSH2/hMLH1 gene is important for diagnosis of HNPCC; however, universal molecular testing of all CRCs would be costly and time-consuming. This evidence concerns the gene MLH1 and hereditary nonpolyposis colon cancer.